EcoDrugPlus

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSSTUG00000030375
Gene Symbol: PSMA2
3 Cross references
266 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSSTUG00000043904
Gene Symbol: PSMA4
3 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSSTUG00000029163
Gene Symbol: PSMA4
3 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSSTUG00000004610
Gene Symbol: PSMA5
3 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSSTUG00000010190
Gene Symbol: PSMA6
3 Cross references
265 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSSTUG00000049555
Gene Symbol: PSMA8
3 Cross references
166 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSSTUG00000025289
Gene Symbol: PSMA8
3 Cross references
167 Possible Orthologues:

Proteasome 20s Subunit Beta 4

Ensembl ID : ENSSTUG00000045103
Gene Symbol: PSMB4
3 Cross references
208 Possible Orthologues:

Proteasome 20s Subunit Beta 5

Ensembl ID : ENSSTUG00000008137
Gene Symbol: PSMB5
1 Cross references
146 Possible Orthologues:

Proteasome 20s Subunit Beta 6

Ensembl ID : ENSSTUG00000031722
Gene Symbol: PSMB6
3 Cross references
180 Possible Orthologues:

Proteasome 20s Subunit Beta 6

Ensembl ID : ENSSTUG00000045711
Gene Symbol: PSMB6
3 Cross references
179 Possible Orthologues:

Proteasome 20s Subunit Beta 7

Ensembl ID : ENSSTUG00000017461
Gene Symbol: PSMB7
3 Cross references
215 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).